Venrock Capital Buys 1.5M Shares in Altimmune

6/26/20

Venrock adds another 1.5M shares to its existing 3M shares in Altimmune (NASDAQ:ALT).

Venrock acquired an aggregate of 1.5M shares directly from the company for $11.3M.

Venrock's total holding of 4.5M shares represents 20.8% stake in the company.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect